PS Ratio: 5.29

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 5.29 is 65% below its estimated 5-year average of 15.16, near the low end of its estimated 5-year range (4.01–83.57).

As of 2026-10-06T18:48:06.769Z. 22.95% below its estimated 12-month average of 6.87.

TARS PS Ratio Metrics

P/S vs. estimated history

At 5.29, P/S is below its estimated 5-year median — higher than 6% of readings in its estimated 5-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Tarsus Pharmaceuticals, Inc. (TARS)?

The P/S ratio for TARS stock is 5.29.

Is Tarsus Pharmaceuticals, Inc.'s P/S ratio high or low?

The P/S ratio of 5.29 is 65% below its estimated 5-year average of 15.16, near the low end of its estimated 5-year range (4.01–83.57).

What is the estimated TTM average P/S ratio for Tarsus Pharmaceuticals, Inc. (TARS)?

The estimated TTM average P/S ratio for TARS stock is 6.87.

What is the estimated 3Y average P/S ratio for Tarsus Pharmaceuticals, Inc. (TARS)?

The estimated 3Y average P/S ratio for TARS stock is 13.63.

What is the estimated 5Y average P/S ratio for Tarsus Pharmaceuticals, Inc. (TARS)?

The estimated 5Y average P/S ratio for TARS stock is 15.16.

Showing the most recent 260 of 1,356 data points. The chart above shows the full history.

Related Metrics